Up next


Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block

170 Views
CNBC Television
0
Published on 16 May 2023 / In News & Politics

Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.

Show more
0 Comments sort Sort By

Up next